stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Mineralys Therapeutics IncMLYS
$16.181.19%0.19

Mineralys Therapeutics Inc (MLYS)

Date: 2026-11-04 16:00O: 16.41H: 16.84L: 15.53C: 16.63Vol: 947.6k
Schlusskurs vom Vortag:
$15.99
Offen:
$16.41
24-Stunden-Volumen:
397,988
Relatives Volumen:
0.18
Marktkapitalisierung:
$1.43B
Einnahmen:
-
Nettoeinkommen (Verlust:
-$151.78M
KGV:
-
EPS:
-$2.06
Netto-Cashflow:
-$136.42M
1W Leistung:
-24.32%
1M Leistung:
-31.53%
6M Leistung:
-45.43%
1Y Leistung:
-59.36%
1-Tages-Spanne:
$15.53$16.47
1-Wochen-Bereich:
$15.33$22.48
52-Wochen-Spanne:
$15.33$47.65

Mineralys Therapeutics Inc Aktie (MLYS) Unternehmensprofil

Firmenname
Mineralys Therapeutics Inc
Telefon
(888) 378-6240
Adresse
150 N. RADNOR CHESTER RD., RADNOR, USA
Mitarbeiter
76
X
-
Nächster Verdiensttermin
2026-11-04
Neueste SEC-Einreichungen
SEC
MLYS-Diskussionen auf X
X

 

Marktkapitalisierung

 

Umsatz

 

Nettogewinn

 

Free Cashflow

 

ENV

 

Mineralys Therapeutics Inc Aktie (MLYS) Hochstufungen & Herabstufungen

DatumAktionAnalytikerRatingänderung
2026-10-12EingeleitetUBSNeutral
2026-04-27EingeleitetTD CowenBuy
2025-06-11EingeleitetJefferiesHold
2024-07-10EingeleitetH.C. WainwrightBuy

Finanzdaten der Mineralys Therapeutics Inc-Aktie (MLYS)

ZeitraumTrendFY 2025FY 2024FY 2023
Enddatum des Zeitraums2025-12-312024-12-312023-12-31
Revenue USD (M)--0.00
Research and development USD (M)132.01168.5870.36
Operating expenses USD (M)170.60192.4084.66
Operating income USD (M)-170.60-192.40-84.66
Income before tax USD (M)---71.90
Income tax expense USD (M)0.00--
Net income USD (M)-154.65-177.81-71.90
Basic EPS USD/shares-2.29-3.66-1.99
Diluted EPS USD/shares-2.29-3.66-1.99
Basic weighted shares shares (M)67.6648.5436.19
Diluted weighted shares shares (M)67.6648.5436.19

Mineralys Therapeutics Inc-Aktie (MLYS) Insiderhandel

  • Officer
    Transaktion
    Proposed Sale
    Kosten
    $22.04
    #Aktien
    3,542
    Wert ($)
    78,066
    #Aktien Gesamt
    0
  • Congleton JonSep 30 '26
    Chief Executive Officer
    Transaktion
    Sale
    Kosten
    $25.46
    #Aktien
    75,000
    Wert ($)
    1,909,665
    #Aktien Gesamt
    528,621
  • Congleton JonSep 30 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $25.46
    #Aktien
    75,000
    Wert ($)
    1,909,662
    #Aktien Gesamt
    0
  • Director
    Transaktion
    Proposed Sale
    Kosten
    $28.81
    #Aktien
    104,320
    Wert ($)
    3,005,303
    #Aktien Gesamt
    0
  • Director
    Transaktion
    Sale
    Kosten
    $28.81
    #Aktien
    104,320
    Wert ($)
    3,005,303
    #Aktien Gesamt
    7,805,718
  • Warren EricSep 21 '26
    Chief Commercial Officer
    Transaktion
    Sale
    Kosten
    $28.12
    #Aktien
    7,438
    Wert ($)
    209,136
    #Aktien Gesamt
    38,400
  • Warren EricSep 21 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $28.12
    #Aktien
    7,438
    Wert ($)
    209,135
    #Aktien Gesamt
    0
  • Warren EricSep 21 '26
    Chief Commercial Officer
    Transaktion
    Option Exercise
    Kosten
    $13.24
    #Aktien
    7,438
    Wert ($)
    98,479
    #Aktien Gesamt
    45,838
  • Officer
    Transaktion
    Proposed Sale
    Kosten
    $27.95
    #Aktien
    417
    Wert ($)
    11,655
    #Aktien Gesamt
    0
  • Karydas DaphneSep 15 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $28.58
    #Aktien
    3,000
    Wert ($)
    85,740
    #Aktien Gesamt
    0
InsiderhandelBeziehungDatumTransaktionKosten#AktienWert ($)#Aktien Gesamt
Rodman David MalcomOfficerOct 13 '26Proposed Sale$22.043,54278,0660
Congleton JonChief Executive OfficerSep 30 '26Sale$25.4675,0001,909,665528,621
Congleton JonOfficerSep 30 '26Proposed Sale$25.4675,0001,909,6620
CATALYS PACIFIC FUND LPDirectorSep 22 '26Proposed Sale$28.81104,3203,005,3030
Slingsby Brian TaylorDirectorSep 22 '26Sale$28.81104,3203,005,3037,805,718
Warren EricChief Commercial OfficerSep 21 '26Sale$28.127,438209,13638,400
Warren EricOfficerSep 21 '26Proposed Sale$28.127,438209,1350
Warren EricChief Commercial OfficerSep 21 '26Option Exercise$13.247,43898,47945,838
Rodman David MalcomOfficerSep 17 '26Proposed Sale$27.9541711,6550
Karydas DaphneOfficerSep 15 '26Proposed Sale$28.583,00085,7400

Mineralys Therapeutics Inc Aktie (MLYS) Neueste Nachrichten

Oct 29, 2026
Oct 29, 2026
Oct 22, 2026
Oct 22, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 09, 2026
Oct 09, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Sep 30, 2026
Sep 30, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 25, 2026
Sep 25, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 15, 2026
Sep 15, 2026
Sep 14, 2026
Sep 14, 2026
Sep 12, 2026
Sep 12, 2026
Sep 10, 2026
Sep 10, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Sep 05, 2026
Sep 05, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026

Ähnlich wie MLYS